Fiona M Campbell
Overview
Explore the profile of Fiona M Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ware J, Allen J, Boughton C, Wilinska M, Hartnell S, Thankamony A, et al.
Diabetes Care
. 2024 Oct;
47(12):2189-2195.
PMID: 39418532
Objective: We aimed to evaluate the longer-term safety and efficacy of hybrid closed-loop (CL) therapy in very young children with type 1 diabetes (T1D). Research Design And Methods: Following a...
2.
Madrid-Valero J, Scott E, Boughton C, Allen J, Ware J, Wilinska M, et al.
J Diabetes Sci Technol
. 2024 Oct;
:19322968241286816.
PMID: 39397750
Background: A diagnosis of type 1 diabetes in a young person can create vulnerability for sleep. Historically it has been rare for young people to be offered a closed-loop system...
3.
Ware J, Boughton C, Allen J, Wilinska M, Hartnell S, Thankamony A, et al.
Diabetes Care
. 2024 Jun;
47(8):1441-1448.
PMID: 38924772
Objective: We evaluated the effect of long-term intensive metabolic control with hybrid closed-loop (CL) on residual C-peptide secretion and glucose control compared with standard insulin therapy in youth with type...
4.
Lakshman R, Najami M, Allen J, Ware J, Wilinska M, Hartnell S, et al.
Diabetes Technol Ther
. 2024 Mar;
26(3):198-202.
PMID: 38444312
The presence of diabetic ketoacidosis (DKA) at diagnosis of type 1 diabetes (T1D) is associated with higher glycated hemoglobin levels over time. We evaluated whether hybrid-closed loop (HCL) therapy from...
5.
Cremer J, Elston R, Campbell F, Kendrick S, Paff M, Quinn G, et al.
Adv Ther
. 2023 Jul;
40(9):4101-4110.
PMID: 37393402
Introduction: Bepirovirsen (GSK3228836) is an antisense oligonucleotide that induced rapid and prolonged hepatitis B surface antigen (HBsAg) reduction with a favorable safety profile following 4 weeks of treatment in participants...
6.
Ghatak A, Boughton C, Allen J, Ware J, Wilinska M, Hartnell S, et al.
Diabetes Technol Ther
. 2023 Jun;
25(9):673-674.
PMID: 37384862
No abstract available.
7.
Alwan H, Ware J, Boughton C, Wilinska M, Allen J, Lakshman R, et al.
Diabetes Technol Ther
. 2023 May;
25(7):485-491.
PMID: 37229591
We aimed to assess whether percentage of time spent in hypoglycemia during closed-loop insulin delivery differs by age group and time of day. We retrospectively analyzed data from hybrid closed-loop...
8.
Fattah M, Boughton C, Ware J, Allen J, Hartnell S, Willinska M, et al.
J Diabetes Sci Technol
. 2022 Dec;
18(3):695-700.
PMID: 36540007
Background: CamAPS FX is a hybrid closed-loop smartphone app used to manage type one diabetes. The closed-loop algorithm has a default target glucose of 5.8 mmol/L (104.5 mg/dL), but users...
9.
Ware J, Wilinska M, Ruan Y, Allen J, Boughton C, Hartnell S, et al.
J Diabetes Sci Technol
. 2022 Dec;
18(4):882-888.
PMID: 36475908
Objective: Many hybrid closed-loop (HCL) systems struggle to manage unusually high glucose levels as experienced with intercurrent illness or pre-menstrually. Manual correction boluses may be needed, increasing hypoglycemia risk with...
10.
de Beaufort C, Schierloh U, Thankamony A, Ware J, Wilinska M, Frohlich-Reiterer E, et al.
Diabetes Care
. 2022 Nov;
PMID: 36350787
Objective: To evaluate the impact of CamAPS FX hybrid closed-loop (HCL) automated insulin delivery in very young children with type 1 diabetes (T1D) on caregivers' well-being, fear of hypoglycemia, and...